Cargando…
Novel combinatorial therapy of oncolytic adenovirus AdV5/3-D24-ICOSL-CD40L with anti PD-1 exhibits enhanced anti-cancer efficacy through promotion of intratumoral T-cell infiltration and modulation of tumour microenvironment in mesothelioma mouse model
INTRODUCTION: Malignant mesothelioma is a rare and aggressive form of cancer. Despite improvements in cancer treatment, there are still no curative treatment modalities for advanced stage of the malignancy. The aim of this study was to evaluate the anti-tumor efficacy of a novel combinatorial therap...
Autores principales: | Garofalo, Mariangela, Wieczorek, Magdalena, Anders, Ines, Staniszewska, Monika, Lazniewski, Michal, Prygiel, Marta, Zasada, Aleksandra Anna, Szczepińska, Teresa, Plewczynski, Dariusz, Salmaso, Stefano, Caliceti, Paolo, Cerullo, Vincenzo, Alemany, Ramon, Rinner, Beate, Pancer, Katarzyna, Kuryk, Lukasz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694471/ http://dx.doi.org/10.3389/fonc.2023.1259314 |
Ejemplares similares
-
Combination Therapy of Novel Oncolytic Adenovirus with Anti-PD1 Resulted in Enhanced Anti-Cancer Effect in Syngeneic Immunocompetent Melanoma Mouse Model
por: Garofalo, Mariangela, et al.
Publicado: (2021) -
Prospects of Replication-Deficient Adenovirus Based Vaccine Development against SARS-CoV-2
por: Garofalo, Mariangela, et al.
Publicado: (2020) -
From Immunosuppression to Immunomodulation - Turning Cold Tumours into Hot
por: Garofalo, Mariangela, et al.
Publicado: (2022) -
From Conventional Therapies to Immunotherapy: Melanoma Treatment in Review
por: Kuryk, Lukasz, et al.
Publicado: (2020) -
Novel Insights Into Mesothelioma Therapy: Emerging Avenues and Future Prospects
por: Kuryk, Lukasz, et al.
Publicado: (2022)